You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xeloda (Capecitabine)

Showing 51 - 75 of 1,514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)

Terminated
Has Results
  • Non-Metastatic Adenocarcinoma of the Rectum
  • Radiation Therapy
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 1, 2021

Rectal Adenocarcinoma Trial in Milwaukee (Capecitabine, Initial Dose of Radiation before Dose Escalation, Cohort A: Dose

Recruiting
  • Rectal Adenocarcinoma
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jul 19, 2022

Pancreatic Cancer Trial in Singapore (oxaliplatin, irinotecan, capecitabine)

Completed
  • Pancreatic Cancer
  • oxaliplatin, irinotecan, capecitabine
  • Singapore, Singapore
    National Cancer Centre
May 28, 2021

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

Completed
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +6 more
  • Houston, Texas
  • +4 more
Aug 31, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain Trial in New York (Capecitabine, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • +8 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Aug 30, 2021

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumors
  • Capecitabine Oral Product
  • +2 more
  • Little Rock, Arkansas
  • +2 more
Aug 11, 2022

Metastatic Triple-Negative Breast Carcinoma Trial in Singapore (Bexarotene, Capecitabine)

Recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
Jun 10, 2022

Rectal Tumors Trial in Guangzhou (Oxaliplatin, capecitabine, Radiation)

Active, not recruiting
  • Rectal Neoplasms
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Jul 26, 2022

Hepatocellular Carcinoma Trial in Albuquerque (Sorafenib & Capecitabine)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • Sorafenib & Capecitabine
  • Albuquerque, New Mexico
  • +2 more
May 11, 2021

Pancreatic Cancer Trial in Seongnam-si, Seoul (Irinotecan Liposomal Injection [Onivyde], Capecitabine, 5-fluorouracil)

Recruiting
  • Pancreatic Cancer
  • Irinotecan Liposomal Injection [Onivyde]
  • +3 more
  • Seongnam-si, Korea, Republic of
  • +1 more
Sep 22, 2021

Breast Cancer Metastatic Trial in Sweden, United Kingdom (Palbociclib, Fulvestrant, Capecitabine)

Active, not recruiting
  • Breast Cancer Metastatic
  • Göteborg, Sweden
  • +8 more
Mar 29, 2022

Liver Metastases Trial in Houston (Leucovorin, 5-FLUOROURACIL, Oxaliplatin)

Recruiting
  • Liver Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Apr 26, 2022

Unresectable Pancreatic Cancer Trial in Milwaukee (Radiation Therapy, Concurrent chemo (Gemcitabine, Capecitabine))

Recruiting
  • Unresectable Pancreatic Cancer
  • Radiation Therapy
  • Concurrent chemotherapy (Gemcitabine, Capecitabine)
  • Milwaukee, Wisconsin
    Froedtert Hospital
Feb 14, 2022

Colorectal Tumors Trial in Pittsburgh (Bevacizumab, Oxaliplatin, Capecitabine)

Terminated
Has Results
  • Colorectal Neoplasms
  • Pittsburgh, Pennsylvania
    NSABP Operations Center
Oct 4, 2021

Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II Trial in Charlottesville (T-DM1, Capecitabine, External Beam

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Charlottesville, Virginia
    University of Virginia
Apr 12, 2022

Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)

Active, not recruiting
  • Rectal Adenocarcinoma
  • Portland, Oregon
    Providence Cancer Center
Mar 22, 2022

Esophagus Cancer Trial in United States (Oxaliplatin, Docetaxel, Capecitabine)

Completed
Has Results
  • Esophagus Cancer
  • Beverly Hills, California
  • +6 more
Oct 29, 2021

Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

Recruiting
  • Gastric Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
  • +7 more
Jan 31, 2022

Stomach Cancer, Gastric (Stomach) Cancer, Tumor of Cardioesophageal Junction Trial in Stanford (bevacizumab, carboplatin,

Completed
Has Results
  • Stomach Cancer
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Jun 29, 2021

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Taxotere, Xeloda)

Completed
Has Results
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 29, 2021

Pancreatic Cancer Trial in Shanghai (Capecitabine)

Recruiting
  • Pancreatic Cancer
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Apr 29, 2021

Triple Negative Breast Cancer Trial in United States (Sacituzumab govitecan-hziy (SG), Pembrolizumab, Capecitabine)

Recruiting
  • Triple Negative Breast Cancer
  • Sacituzumab govitecan-hziy (SG)
  • +2 more
  • Glendale, Arizona
  • +7 more
Jan 26, 2023

Metastatic Triple Negative Breast Cancer Trial (pembrolizumab, capecitabine, eribulin)

Completed
Has Results
  • Metastatic Triple Negative Breast Cancer
  • pembrolizumab
  • +4 more
  • (no location specified)
Nov 9, 2021